{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T12:32:36Z","timestamp":1792672356771,"version":"4.5.0"},"reference-count":57,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100020884","name":"Agencia Nacional de Investigaci\u00f3n y Desarrollo","doi-asserted-by":"publisher","award":["IMII P09\/016-F, CONICYT FONDAP-1513001, FONDECYT 1180241, FONDECYT 1180173."],"award-info":[{"award-number":["IMII P09\/016-F, CONICYT FONDAP-1513001, FONDECYT 1180241, FONDECYT 1180173."]}],"id":[{"id":"10.13039\/501100020884","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Immune checkpoint inhibitors have significantly advanced the treatment of gastric cancer (GC), yet therapeutic resistance remains common due to the immunosuppressive tumor microenvironment and redundancy among inhibitory checkpoints. Tim-3 (HAVCR2) is an emerging immune checkpoint receptor implicated in tumor immune evasion. However, the role of its ligand, Galectin-9 (Gal-9, LGALS9), in GC pathogenesis and therapy resistance remains poorly understood. We performed bioinformatic analysis of The Cancer Genome Atlas (TCGA) stomach adenocarcinoma (STAD) dataset to assess LGALS9 and HAVCR2 expression and their clinical correlations. We also evaluated associations between LGALS9 expression and immune cell signatures. Functional ex vivo assays were conducted to investigate the effects of Gal-9 on CD8\u207a T cell function and Treg suppressive activity in the context of Tim-3 signaling. Our analysis revealed that both LGALS9 and HAVCR2 are upregulated in gastric tumors and associated with poor patient survival. HAVCR2 expression was significantly higher in invasive adenocarcinomas. LGALS9 expression strongly correlated with signatures of CD8\u207a T cell dysfunction and increased infiltration of regulatory T cells (Tregs). Functionally, Gal-9 promoted Treg suppressive activity and CD8\u207a T cell dysfunction ex vivo through Tim-3 engagement, independently of PD-1 signaling. These findings suggest that Gal-9 contributes to immune evasion in GC by promoting Treg expansion and CD8\u207a T cell exhaustion, potentially driving resistance to anti-PD-1 therapy. We propose circulating Gal-9 as a candidate biomarker of anti-PD-1 resistance and support the rationale for combined blockade of PD-1 and Tim-3 to enhance immunotherapeutic efficacy in GC.<\/jats:p>","DOI":"10.3389\/fimmu.2025.1600792","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T01:28:56Z","timestamp":1751333336000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":25,"title":["Galectin-9 and Tim-3 in gastric cancer: a checkpoint axis driving T cell exhaustion and Treg-mediated immunosuppression independently of anti-PD-1 blockade"],"prefix":"10.3389","volume":"16","author":[{"given":"Charlotte N.","family":"Hill","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela","family":"Maita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille","family":"Cabrolier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constanza","family":"Aros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Maria","family":"Vega-Letter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela","family":"Gonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexis M.","family":"Kalergis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Luz-Crawford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gareth I.","family":"Owen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,7,1]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-13-1057","article-title":"Gastric cancer: descriptive epidemiology, risk factors, screening, and prevention","volume":"23","author":"Karimi","year":"2014","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"B2","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2019.07.045","article-title":"Burden of gastric cancer","volume":"18","author":"Thrift","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.4067\/S0718-40262011000200004","article-title":"Registry of gastric cancer evaluation in Chile (REGATE): Basal clinical features of 523 patients","volume":"63","author":"M\u00fcller","year":"2011","journal-title":"Rev Chil Cir"},{"key":"B5","doi-asserted-by":"publisher","first-page":"707","DOI":"10.3332\/ecancer.2016.707","article-title":"The current situation for gastric cancer in Chile","volume":"10","author":"Caglevic","year":"2016","journal-title":"Ecancermedicalscience"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2003.04.130","article-title":"Randomized phase III trial of fluorouracil alone versus fluorouracil plus cisplatin versus uracil and tegafur plus mitomycin in patients with unresectable, advanced gastric cancer: The Japan Clinical Oncology Group Study (JCOG9205)","volume":"21","author":"Ohtsu","year":"2003","journal-title":"J Clin Oncol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.2217\/fon-2017-0436","article-title":"Pembrolizumab for treatment of advanced gastric and gastroesophageal junction adenocarcinoma","volume":"14","author":"Joshi","year":"2018","journal-title":"Future Oncol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2018.0013","article-title":"Safety and efficacy of pembrolizumab monotherapy in patients with previously treated advanced gastric and gastroesophageal junction cancer: phase 2 clinical KEYNOTE-059 trial","volume":"4","author":"Fuchs","year":"2018","journal-title":"JAMA Oncol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20100643","article-title":"Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity","volume":"207","author":"Sakuishi","year":"2010","journal-title":"J Exp Med"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-13-2908","article-title":"PD-1 and Tim-3 regulate the expansion of tumor antigen-specific CD8+ T cells induced by melanoma vaccines","volume":"74","author":"Fourcade","year":"2014","journal-title":"Cancer Res"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1009731107","article-title":"Cooperation of Tim-3 and PD-1 in CD8 T-cell exhaustion during chronic viral infection","volume":"107","author":"Jin","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0903275","article-title":"Tim-3\/galectin-9 pathway: regulation of Th1 immunity through promotion of CD11b+Ly-6G+ myeloid cells","volume":"185","author":"Dardalhon","year":"2010","journal-title":"J Immunol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.immuni.2018.11.014","article-title":"Checkpoint blockade immunotherapy induces dynamic changes in PD-1-CD8+ Tumor-infiltrating T cells","volume":"50","author":"Kurtulus","year":"2019","journal-title":"Immunity"},{"key":"B14","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.immuni.2018.12.021","article-title":"Intratumoral tcf1+PD-1+CD8+ T cells with stem-like properties promote tumor control in response to vaccination and checkpoint blockade immunotherapy","volume":"50","author":"Siddiqui","year":"2019","journal-title":"Immunity"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.aai8593","article-title":"The TCF1-Bcl6 axis counteracts type I interferon to repress exhaustion and maintain T cell stemness","volume":"1","author":"Wu","year":"2016","journal-title":"Sci Immunol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20180684","article-title":"High-dimensional single cell analysis identifies stem-like cytotoxic CD8+ T cells infiltrating human tumors","volume":"215","author":"Brummelman","year":"2018","journal-title":"J Exp Med"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-019-0312-6","article-title":"Subsets of exhausted CD8+ T cells differentially mediate tumor control and respond to checkpoint blockade","volume":"20","author":"Miller","year":"2019","journal-title":"Nat Immunol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"10501","DOI":"10.1038\/ncomms10501","article-title":"Adaptive resistance to therapeutic PD-1 blockade is associated with upregulation of alternative immune checkpoints","volume":"7","author":"Koyama","year":"2016","journal-title":"Nat Commun"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0047648","article-title":"Upregulation of the Tim-3\/galectin-9 pathway of T cell exhaustion in chronic hepatitis B virus infection","volume":"7","author":"Nebbia","year":"2012","journal-title":"PloS One"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-11-0096","article-title":"Anti-TIM3 antibody promotes T cell IFN-\u03b3-mediated antitumor immunity and suppresses established tumors","volume":"71","author":"Ngiow","year":"2011","journal-title":"Cancer Res"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-10-310425","article-title":"Coexpression of Tim-3 and PD-1 identifies a CD8+ T-cell exhaustion phenotype in mice with disseminated acute myelogenous leukemia","volume":"117","author":"Zhou","year":"2011","journal-title":"Blood"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00639-09","article-title":"Negative immune regulator Tim-3 is overexpressed on T cells in hepatitis C virus infection and its blockade rescues dysfunctional CD4+ and CD8+ T cells","volume":"83","author":"Golden-Mason","year":"2009","journal-title":"J Virol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.4161\/onci.23849","article-title":"TIM3+FOXP3+ regulatory T cells are tissue-specific promoters of T-cell dysfunction in cancer","volume":"2","author":"Sakuishi","year":"2013","journal-title":"Oncoimmunology"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0058006","article-title":"Tim-3 expression defines regulatory T cells in human tumors","volume":"8","author":"Yan","year":"2013","journal-title":"PloS One"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0030676","article-title":"TIM-3 expression characterizes regulatory T cells in tumor tissues and is associated with lung cancer progression","volume":"7","author":"Gao","year":"2012","journal-title":"PloS One"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2016.01.036","article-title":"Downregulation of IL-10 secretion by Treg cells in osteoarthritis is associated with a reduction in Tim-3 expression","volume":"79","author":"Li","year":"2016","journal-title":"BioMed Pharmacother"},{"key":"B27","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s13046-018-0713-7","article-title":"Blockade of TIM3 relieves immunosuppression through reducing regulatory T cells in head and neck cancer","volume":"37","author":"Liu","year":"2018","journal-title":"J Exp Clin Cancer Res"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1007\/s13277-015-4237-x","article-title":"Ovarian carcinoma-infiltrating regulatory T cells were more potent suppressors of CD8(+) T cell inflammation than their peripheral counterparts, a function dependent on TIM3 expression","volume":"37","author":"Bu","year":"2016","journal-title":"Tumour Biol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0081799","article-title":"Decreased galectin-9 and increased Tim-3 expression are related to poor prognosis in gastric cancer","volume":"8","author":"Jiang","year":"2013","journal-title":"PloS One"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3892\/or.2018.6627","article-title":"Association between Tim\u22123 and Gal\u22129 expression and gastric cancer prognosis","volume":"40","author":"Wang","year":"2018","journal-title":"Oncol Rep"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.5152\/tjg.2017.16346","article-title":"Prognostic value of tumoral expression of galectin-9 in gastric cancer","volume":"28","author":"Choi","year":"2017","journal-title":"Turk J Gastroenterol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.15954","article-title":"TIM-3 is a potential prognostic marker for patients with solid tumors: A systematic review and meta-analysis","volume":"8","author":"Zhang","year":"2017","journal-title":"Oncotarget"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-018-0136-1","article-title":"Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response","volume":"24","author":"Jiang","year":"2018","journal-title":"Nat Med"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1810580115","article-title":"Identification and validation of a tumor-infiltrating Treg transcriptional signature conserved across species and tumor types","volume":"115","author":"Magnuson","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B35","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1186\/s13148-017-0413-8","article-title":"MicroRNA-335-5p is a potential suppressor of metastasis and invasion in gastric cancer","volume":"9","author":"Sandoval-B\u00f3rquez","year":"2017","journal-title":"Clin Epigen"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.v136.4","article-title":"Peroxisome proliferator-activated receptor \u03b3 upregulates galectin-9 and predicts prognosis in intestinal-type gastric cancer","volume":"136","author":"Cho","year":"2015","journal-title":"Int J Cancer"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-04-0861","article-title":"Galectin-9 as a prognostic factor with antimetastatic potential in breast cancer","volume":"11","author":"Irie","year":"2005","journal-title":"Clin Cancer Res"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.physbeh.2017.03.040","article-title":"Orexin activation counteracts decreases in nonexercise activity thermogenesis (NEAT) caused by high-fat diet","volume":"176","author":"Bunney","year":"2017","journal-title":"Physiol Behav"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1172\/JCI46102","article-title":"Exhaustion of tumor-specific CD8+ T cells in metastases from melanoma patients","volume":"121","author":"Baitsch","year":"2011","journal-title":"J Clin Invest"},{"key":"B40","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1038\/s41591-018-0057-z","article-title":"A transcriptionally and functionally distinct PD-1+ CD8+ T cell pool with predictive potential in non-small-cell lung cancer treated with PD-1 blockade","volume":"24","author":"Thommen","year":"2018","journal-title":"Nat Med"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0801497105","article-title":"Selective expansion of a subset of exhausted CD8 T cells by alphaPD-L1 blockade","volume":"105","author":"Blackburn","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.77.8.4911-4927.2003","article-title":"Viral persistence alters CD8 T-cell immunodominance and tissue distribution and results in distinct stages of functional impairment","volume":"77","author":"Wherry","year":"2003","journal-title":"J Virol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-019-0235-4","article-title":"CD8+ T cell states in human cancer: insights from single-cell analysis","volume":"20","author":"van der Leun","year":"2020","journal-title":"Nat Rev Cancer"},{"key":"B44","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/j.cell.2018.11.043","article-title":"Dysfunctional CD8 T cells form a proliferative, dynamically regulated compartment within human melanoma","volume":"176","author":"Li","year":"2019","journal-title":"Cell"},{"key":"B45","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1016\/j.cell.2018.10.038","article-title":"Defining T cell states associated with response to checkpoint immunotherapy in melanoma","volume":"175","author":"Sade-Feldman","year":"2018","journal-title":"Cell"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20190249","article-title":"Single-cell transcriptomic analysis of tissue-resident memory T cells in human lung cancer","volume":"216","author":"Clarke","year":"2019","journal-title":"J Exp Med"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-018-0078-7","article-title":"Single-cell profiling of breast cancer T cells reveals a tissue-resident memory subset associated with improved prognosis","volume":"24","author":"Savas","year":"2018","journal-title":"Nat Med"},{"key":"B48","doi-asserted-by":"publisher","first-page":"1010428317698352","DOI":"10.1177\/1010428317698352","article-title":"TIM-3 plays a more important role than PD-1 in the functional impairments of cytotoxic T cells of Malignant Schwannomas","volume":"39","author":"Li","year":"2017","journal-title":"Tumour Biol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1324-y","article-title":"TOX is a critical regulator of tumour-specific T cell differentiation","volume":"571","author":"Scott","year":"2019","journal-title":"Nature"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1111\/imm.2018.154.issue-4","article-title":"The opposing roles of CD4+ T cells in anti-tumour immunity","volume":"154","author":"Ahrends","year":"2018","journal-title":"Immunology"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2019.05.003","article-title":"Treg-mediated acquired resistance to immune checkpoint inhibitors","volume":"457","author":"Saleh","year":"2019","journal-title":"Cancer Lett"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1111\/imm.2018.155.issue-2","article-title":"ImmTAC\/Anti-PD-1 antibody combination to enhance killing of cancer cells by reversing regulatory T-cell-mediated immunosuppression","volume":"155","author":"Zhang","year":"2018","journal-title":"Immunology"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2014.06.011","article-title":"Galectin-9-CD44 interaction enhances stability and function of adaptive regulatory T cells","volume":"41","author":"Wu","year":"2014","journal-title":"Immunity"},{"key":"B54","doi-asserted-by":"publisher","first-page":"32024","DOI":"10.1038\/srep32024","article-title":"Blockage of galectin-receptor interactions by \u03b1-lactose exacerbates plasmodium berghei-induced pulmonary immunopathology","volume":"6","author":"Liu","year":"2016","journal-title":"Sci Rep"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-003571","article-title":"TIM-3 blockade enhances IL-12-dependent antitumor immunity by promoting CD8+ T cell and XCR1+ dendritic cell spatial co-localization","volume":"10","author":"Gardner","year":"2022","journal-title":"J Immunother Cancer"},{"key":"B56","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1038\/s41467-021-21099-2","article-title":"Galectin-9 interacts with PD-1 and TIM-3 to regulate T cell death and is a target for cancer immunotherapy","volume":"12","author":"Yang","year":"2021","journal-title":"Nat Commun"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.v6i29","article-title":"LAG3 and PD1 co-inhibitory molecules collaborate to limit CD8+ T cell signaling and dampen antitumor immunity in a murine ovarian cancer model","volume":"6","author":"Huang","year":"2015","journal-title":"Oncotarget"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1600792\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T01:28:58Z","timestamp":1751333338000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1600792\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,1]]},"references-count":57,"alternative-id":["10.3389\/fimmu.2025.1600792"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1600792","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,1]]},"article-number":"1600792"}}